Anticoagulation and vascular anomalies
Open Access
- 3 April 2024
- journal article
- review article
- Published by Elsevier in Research and Practice in Thrombosis and Haemostasis
- Vol. 8 (3) , 102402
Abstract
No abstract availableKeywords
Funding Information
- Pfizer
This publication has 39 references indexed in Scilit:
- Response to sirolimus in capillary lymphatic venous malformations and associated syndromes: Impact on symptomatology, quality of life, and radiographic responsePediatric Blood & Cancer, 2023
- How we approach coagulopathy with vascular anomaliesPediatric Blood & Cancer, 2022
- Coagulopathy and related complications following sclerotherapy of congenital venous malformationsPediatric Blood & Cancer, 2022
- Analyzing coagulation dynamics during treatment of vascular malformations with thromboelastographyPediatric Blood & Cancer, 2020
- Peri‐procedural Anticoagulation in Patients with Head and Neck Versus Extremity Venous MalformationsThe Laryngoscope, 2020
- Retrospective study of hematologic complications in patients with slow‐flow vascular malformations undergoing sclerotherapyPediatric Blood & Cancer, 2020
- Effect of sirolimus on coagulopathy of slow‐flow vascular malformationsPediatric Blood & Cancer, 2019
- Characterization of thrombosis in patients with Proteus syndromeAmerican Journal of Medical Genetics Part A, 2017
- Association of Localized Intravascular Coagulopathy With Venous MalformationsArchives of Dermatology, 2008
- Coagulation Disorders in Patients With Venous Malformation of the Limbs and TrunkArchives of Dermatology, 2008